Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E

NCT01813487 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: HBsAg vaccine with Entecavir

Sponsor

Genexine, Inc.